Kevin Balthaser
Fortuna: 852 911 $ al 31/05/2026
Fortuna: 852 911 $ al 31/05/2026
Kevin Balthaser currently holds the position of Chief Financial Officer & Accounting Officer at Aclaris Therapeutics, Inc. since 2023 and has been with the company since 2017.
Kevin is also a member of The American Institute of Certified Public Accountants.
Mr. Balthaser completed undergraduate studies at The Pennsylvania State University and earned an MBA from Villanova University in 1990.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 14/04/2026 | 187.453 ( 0,13 % ) | 852 911 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Director Financiero/CFO | 01/01/2023 |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.